Skip to main content

Table 4 Demographic and clinical data of diabetic subjects with and without MALE

From: Association between omentin-1 and major cardiovascular events after lower extremity endovascular revascularization in diabetic patients: a prospective cohort study

 

NO MALE (n = 111)

MALE (n = 96)

p value

Age, years

74.901

75.062

0.898

Men:women, n

68:43

76:20

0.005

BMI, kg/m2

26.757

26.675

0.364

Diabetes duration, years

11.486

11.357

0.289

HBP, n (%)

73 (65,8)

71 (74.0)

0.201

HCHOL, n (%)

59 (53.2)

54 (56.3)

0.655

CAD, n (%)

52 (46.8)

43 (44.8)

0.767

CVD, n (%)

47 (42.3)

54 (56.3)

0.046

Current smokers, n (%)

59 (53.2)

68 (70.8)

0.009

Past smokers, n (%)

8 (7.2)

15 (15.6)

0.055

Never smoked, n (%)

44 (39.6)

13 (13.5)

 < 0.001

Rutherford 4, n (%)

78 (70.3)

34 (35.4)

 < 0.001

Rutherford 5, n (%)

33 (29.7)

62 (64.6)

 < 0.001

Ankle Brachial Index

0.645

0.55

 < 0.001

Total cholesterol, mg/dL

215.582

223.513

0.011

LDL cholesterol, mg/dL

107.898

118.067

 < 0.001

Triglycerides, mg/dL

172.009

172.854

0.475

Glucose, mg/dL

127.611

128.441

0.539

HbA1C, %

8.919

8.857

0.519

eGFR mL/min/1.73 m2

72.489

73.24

0.611

Omentin-1 ng/mL

31.339

26.672

 < 0.001

  1. BMI Body Mass Index, HBP High Blood Pression, HCHOL Hypercholesterolemia, CAD Coronary Artery Disease, CVD Cerebrovascular Disease, LDL low-density lipoprotein, eGFR estimated glomerular filtration rate. Statistical test performed with Student’s t-test or with Chi square test, when appropriate.
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840